# Atorvastatin for HAART Suboptimal Responders

> **NCT01766076** · PHASE3 · COMPLETED · sponsor: **Makerere University** · enrollment: 30 (actual)

## Conditions studied

- Acquired Immune Deficiency Syndrome Virus

## Interventions

- **OTHER:** atorvastatin, Lipitor®
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01766076
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-02
- **Final completion:** 2014-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-05-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01766076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01766076, "Atorvastatin for HAART Suboptimal Responders". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01766076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*